Pramipexole-induced somnolence and episodes of daytime sleep.
about
Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humansSide effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacologyPhysicians' role in the determination of fitness to drive in patients with Parkinson's disease: systematic review of the assessment tools and a call for national guidelinesComparison of pramipexole with and without domperidone co-administration on alertness, autonomic, and endocrine functions in healthy volunteers.Observations on sleep-disordered breathing in idiopathic Parkinson's disease.Sleep attacks in patients taking dopamine agonists: reviewA review of pramipexole and its clinical utility in Parkinson's disease.Sleep disorders in Parkinson's disease: the nursing role.Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class.Update on the use of pramipexole in the treatment of Parkinson's disease.Current status of symptomatic medical therapy in Parkinson's diseaseAntiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice.Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson's Disease.Excessive daytime sleepiness in patients with Parkinson's disease.Nonmotor symptoms in Parkinson's disease.Sleep disturbances in Taiwanese patients with Parkinson's disease.Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment.Adverse effects in the treatment of Parkinson's disease.Second-generation dopamine agonists and recollection impairments in Parkinson's disease.Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): placebo-controlled, polysomnographic case report.Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.Piribedil-induced sleep attacks in Parkinson's disease.Sleep attacks in Parkinson's disease induced by Entacapone, a COMT-inhibitor.Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment.Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers.Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management.Sleep Attacks in Patients With Parkinson's Disease on Dopaminergic Medications: A Systematic ReviewParkinson's disease and sleep/wake disturbances
P2860
Q24654140-1F4DE90E-7933-48FF-805C-0E2B50ECAC19Q26738349-87F8158D-5CC5-4A27-9C7C-358B894F8C5EQ28074765-B8D272D6-A17B-4121-95F2-6F1B2B0A8678Q30492844-27404536-0038-4D94-9871-15E2D56B1D7CQ33812515-EEA6E3F5-E051-49D7-9784-2E83DF0BB47FQ33875484-C8218BC6-1FBE-461D-B625-5E60022F7CC8Q34519277-F148222B-5584-4660-A329-1A0D8D9C33ABQ34778880-28652A86-0426-4251-BBB6-68B2F7F34697Q35211225-F1DC7D04-D967-4668-801E-F31B86817B32Q35485478-65F3E80E-07E1-421C-BF89-936F085A4E4FQ36659079-C93A694E-ADF7-4840-937A-DCFDB8AE8E79Q36842189-05FB4EB7-E23F-449D-96C6-62BE7FEFB624Q37131229-D2B1729C-6046-4F3B-AC43-EBB6403D45D4Q37173959-431FAFCE-4ECE-4E32-96BB-CF0DE6702873Q37643888-7836479B-D38C-48F5-B62B-99166CE80F93Q37654377-8F7AA5F9-8EE7-480E-8D2A-D806E0B81964Q37842431-D304EA24-92C0-4156-A0C0-7534775E6DA4Q37950422-96693390-1B58-481F-A507-613523D4FA79Q42655947-40A26998-F69E-4A24-8E0B-1837C2E6F027Q43057272-B877B5FD-FB89-4B90-AFA6-850A02CDAB18Q43265598-7A1C7CBC-B29B-48C5-9675-676382E44692Q43480133-D00D4C40-4B62-4FD6-9311-8700B3FCB48BQ43827138-B8C5C93E-8267-456F-975D-D6A3119D73CDQ44060150-75709EF6-62D5-4648-B8E2-E26022B1F5FFQ44165230-1DD3DE24-28A7-4718-85CD-EDAC7A5A9F4FQ44316809-255E2736-D355-4525-BF3F-064962A7C124Q44316812-3F2F9F94-EC5C-49C4-AFD8-47A069BE94CFQ44825538-5844334A-31D7-482E-A163-6F4914B17B40Q45252416-E529D3D4-BCED-47F0-967E-6936B9E0484BQ46886108-9EF8CB8F-B42F-4FF8-96B6-0706C7598BAEQ52583507-FD732598-D728-4C4C-85EE-FB1C841B5A2DQ56441137-65B32FE2-963F-4597-823D-117DAD0B1B60Q58913404-3756C733-E1EA-4064-8BF1-80193A98DD18
P2860
Pramipexole-induced somnolence and episodes of daytime sleep.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pramipexole-induced somnolence and episodes of daytime sleep.
@ast
Pramipexole-induced somnolence and episodes of daytime sleep.
@en
type
label
Pramipexole-induced somnolence and episodes of daytime sleep.
@ast
Pramipexole-induced somnolence and episodes of daytime sleep.
@en
prefLabel
Pramipexole-induced somnolence and episodes of daytime sleep.
@ast
Pramipexole-induced somnolence and episodes of daytime sleep.
@en
P2093
P2860
P1433
P1476
Pramipexole-induced somnolence and episodes of daytime sleep.
@en
P2093
Anderson WM
Zesiewicz TA
P2860
P304
P356
10.1002/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N
P407
P577
2000-07-01T00:00:00Z